U.S. will drive regional transcatheter cardiac pacemaker market share in 2016 due to
presence of leading manufacturers namely Medtronic providing affordable products for
the procedure. According to National Center for Biotechnology Information, U.S.
National Library of Medicine, around 700,000 pacemakers are implanted annually
across the globe with more than 250,000 implanted in the United States. Increasing
prevalence of hypertrophic cardiomyopathy, about 1 in 500, growing prevalence of
hypertension, established healthcare infrastructure, existence of strategic
reimbursement structure and large per capita healthcare expenditure will drive the
regional industry share.
Browse key industry insights from the report “Transcatheter Cardiac Pacemaker
Market Size By position (Left Ventricle, Right Ventricle), By End Use (Hospitals,
Clinics), Industry Analysis Report, Regional Outlook (U.S., Canada, Germany, UK,
Italy, Spain, France, Poland, China, India, Japan, Australia, Malaysia, Thailand,
Brazil, Mexico, South Africa, Saudi Arabia), Application Development Potential,
Price Trends, Competitive Market Share & Forecast, 2017 – 2024” in detail along
with the table of contents:
https://www.gminsights.com/industry-analysis/transcatheter-cardiac-pacemaker-
market
European transcatheter cardiac pacemaker market will witness tremendous growth due
to growing geriatric population and high prevalence of heart rhythm disorder. Growing
clinical trials, increase in survival rates for those affected by complex congenital heart
disease and favorable growth opportunities for industry players will increase the
product demand. Leadless pacemaker is part of a post-market study in the European
Union. According to European Heart Journal, around 400 patients per million
population every year undergoes cardiac resynchronization therapy in the region.
Indian will grow at fastest rate among the other Asia Pacific countries owing to the
presence of specialization in the field of heart care, innovative methods for cardiac
treatment and growing need for medical care. The country has become one of the
favorite medical tourism destination that provides excellent medical facilities
comparable with other western countries, numerous economic government initiatives,
more investment opportunities for multinational players will boost the industry growth.
In February 2017, Pharmaceuticals and Medical Devices Agency in Japan approved the
implementation of Micra that will expand country’s transcatheter cardiac pacemaker
market over the coming years.
Mexico transcatheter cardiac pacemaker market will become more competitive owing
to presence of skilled cardiac surgeon and increased number of fast, efficient and
affordable cardiac procedures. Moreover, availability of high-quality medical care at low
cost will further increase the product application.
2 | Page